(S)-2-(((S)-1-Ethoxy-1-oxopentan-2-yl)amino)propanoic acid, 95.0%, 10g

3-((4-Methylpiperazin-1-yl)methyl)phenylboronic acid, 97%, 1g

2-Chloro-3-hydroxypyridine, 98.0%, 5g

4H-Chromen-4-one, 95.0%, 100g

2-(4-(Methoxymethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)aniline, 98%, 50mg

Tris(2-aminoethyl)amine, 98.0%, 1g

2-[[[3-METHYL-4-(2,2,2-TRIFLUORO-ETHOXY)-PYRIDIN-2-YL]METHYL]SULFINYL]-1H-BENZO[D]IMIDAZOLE, 95%, 25g

(E)-Ethyl 3-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate, 95.0%, 100mg

REVEFENACIN, 95%, 1mg

3-(2-Bromoimidazo[2,1-b]thiazol-6-yl)propanoic acid hydrochloride, 95.0%, 1g

[(tert-butoxy)carbonyl]({[4-(dimethyliminiumyl)-1,4-dihydropyridin-1-yl]sulfonyl})azanide, 98%, 1g

Unité de filtration avec membrane SFCA Taille des pores 0,2 μm, 150 ml, 150 ml, 50 mm, 12 pièce(s)